Targeted Cognitive Game Training Enhances Cognitive Performance in Multiple Sclerosis Patients Treated With Interferon Beta 1-a

doi:10.21203/rs.3.rs-725383/v1

Background

Prevention of cognitive decline in Multiple Sclerosis (MS) is of major importance. We explored the effect of short-term computerized game training on cognitive performance in MS patients with mild cognitive impairment.

Methods

We enrolled in this prospective study 100 eligible MS patients treated with Interferon-beta-1a (Rebif). All had mild cognitive impairment in either executive function or information processing speed. Patients were randomized 1:1 to either use the cognitive games platform by

HappyNeuron (HN) or receive no intervention. Executive function and information processing speed scores were measured at 3 and 6 months from baseline to evaluate the effect of game training on cognitive scores.

Results

In both executive function and information processing speed, the game Training group showed significant improvement after 3 and 6 months. The Non-Training group showed mild deterioration in both domains at 3 months, and further deterioration that became significant at 6 months in executive function. Furthermore, at 6 months, the percent of patients in the Training group that improved or remained stable in both cognitive domains was significantly higher compared to the Non-Training group.

Conclusions

Our findings suggest that cognitive game training has a beneficial effect on cognitive performance in MS patients suffering from mild cognitive impairment. While further evaluation is required to assess the longevity of that effect, we nonetheless recommend to MS patients to be engaged in cognitive gaming practice as part of a holistic approach to treating their condition.

Neurobiology of Disease

Physical Medicine & Rehab

Multiple sclerosis

cognition

information processing speed

executive function

games

training

interferon-beta-1-a

plasticity.

Cognitive impairment is reported to occur in multiple sclerosis (MS) patients along the disease course (1) and can present even in the early disease phase (2, 3).

However, only a few studies assessed the effect of cognitive rehabilitative practice by cognitive training on cognitive performance in MS using various models of cognitive games to improve brain plasticity (4–7). A recent systematic review and meta-analysis (8) assessing the effects of computerized cognitive training on cognitive outcomes in adults with MS found small to moderate effect sizes for attention/processing speed, executive functions, and verbal and visuospatial memory. These key cognitive domains are the ones most commonly affected in MS-related cognitive impairment (9, 10).

The scientific support for the beneficial outcome of brain training, defined as a process that enhances a cognitive skill through engagement in a particular cognitive exercise (11),

thrives on the expected effects of neuroplasticity. Neuroplasticity encodes the ability of the nervous system to respond to intrinsic and extrinsic stimuli by reorganizing its structure, function, and connections. Such plasticity is adaptive when associated with a gain in function (12). Moreover, repetitive training is reported to trigger neural changes within a short period (13).

The value of enriched environments in enhancing brain recovery at both structural and chemical levels has been repeatedly demonstrated in animal studies (14, 15). These studies illustrated that environments facilitate enhanced cognitive, motor, and sensory stimulations mainly by applying animal housing conditions with complex arrangements of toys, platforms, and tunnels being changed every few days, shown to promote motor learning and memory. In accordance, in humans recovering from brain injuries, enriched environments promote better motor recovery and augment neuronal plasticity within non-injured, functionally connected brain regions (16, 17). The rationale for motor and sensory training is based not only on direct activation of the weakened muscles or awakening sensory stimuli in a numb limb but also on the possibility that training will enhance neuroplasticity by affecting cellular mechanisms that determine myelin sheath extension and stabilization around axons. It is conceivable to hypothesize that neuroplasticity may be enhanced by cognitive training. Cognitive game training is an innovative approach that aims to improve cognitive skills by repeated sets of targeted gaming exercises. Using cognitive gamification might help overcome one of the core challenges of conventional cognitive rehabilitation, that of motivation to train; these cognitive tasks tend to be highly repetitive with a need for multiple training sessions and often bore the patients and reduce compliance. The ability to train cognitive aspects using computerized gamification approaches that transform conventional tasks into a more entertaining though no less difficult cognitive practice, can maximize user engagement and result in better cognitive outcomes, specifically in patients at high risk for cognitive decline (18, 19). Moreover, web-based cognitive games are easily accessible and have already demonstrated a benefit among healthy (20), older adults (21), and adults with chronic acquired brain injury (22). We have recently reported the correlations between web-based cognitive game training tasks and cognitive performance in patients with multiple sclerosis and demonstrated the correlations between specific games and cognitive performance (23). In the current prospective study, we further evaluated a large group of MS patients with mild cognitive impairment, all treated with the same immunomodulatory drug, and assessed whether targeted cognitive game training for a six months period provides cognitive benefits within the domains of information processing speed and executive functioning.

Study design and patient population

This was a single-center, randomized prospective study, conducted in the Multiple Sclerosis Center, Sheba Medical Center, Tel Hashomer, Israel. Ethical approval to conduct the study was granted by the Sheba Medical Center Ethics Committee (Institutional Review Board number SMC-333016), and each participant signed written informed consent. Data were collected between May 2016 and February 2021. Data is available upon request from the authors of this study.

Inclusion criteria were as follows: (1) Patients diagnosed with relapsing-remitting multiple sclerosis or secondary-progressive multiple sclerosis according to revised McDonald Criteria 2010 (24). (2) Age between 18-55 years. (3) Mild cognitive impairment, defined as a cognitive test performance in information processing speed or executive function of a score < 95. (4) Current treatment with Rebif® and RebiSmart 2.0 (in doses of 22 or 44 mcg subcutaneous, three times a week) (5) Signed written informed consent.

Exclusion criteria were as follows: (1) Steroid treatment within the last 3 months. (2) Severe cognitive decline that prevents cognitive assessment. (3) Significant depression and/or anxiety. (4) Visual impairment or upper extremity motor disability the precludes the ability to perform cognitive training. Demographic and clinical data were collected for all of the study subjects and included age, gender, years of education, disease duration, and disability status as measured by the Expanded Disability Status Scale (EDSS) (25).

Cognitive assessments

Cognitive assessment was performed using the computerized MindStreams Global Assessment Battery (NeuroTrax Corp., Bellaire, TX, USA), which has been validated in MS population (2), and was reported to have good reliability and validity relative to paper-based tests (9). Executive function and information processing speed domains were evaluated, as they reflect the most vulnerable cognitive impairments in MS patients. Outcome parameters accuracy and response time were normalized for age and education according to stratifications of a normative database of cognitively healthy subjects to fit an IQ-like scale (mean: 100, SD: 15). Value of 95 was defined as the cutoff for mild cognitive impairment in either executive function or information processing speed domains.

Randomization

Patients eligible for the study signed written informed consent and were randomized to either the game training or the non-game training group. Randomization was performed for cognitive performance and EDSS which were the major important variables to ensure similar cognitive performance and disease characteristics before cognitive game practice.

Sample size calculation

A sample size calculation demonstrated that a sample of 42 subjects in each group will yield 80% power to detect a difference in means of 5.000 (the difference between a Group 1 mean, m1, of 0.0 and a Group 2 mean, m2, of -5.0) assuming that the common standard deviation is 8 using a two-group t-test with a 0.050 two-sided significance level.

The expected drop-out rate in this study was 20%, hence, we aimed to enroll 48 subjects in each group.

Cognitive neuro-game training

Cognitive neuro-game training using HappyNeuron platform (HN, https://www.happyneuronpro.com/en) was performed by the patients randomized into the training group twice weekly, each session lasting 30 minutes, for 6 months. HappyNeuron platform is a web-based cognitive training game platform. Nine cognitive exercises developed by Happyneuron for cognitive training were applied for practice during this study. The HAPPYneuron brain training cognitive game-platform is aimed to stimulate various cognitive aspects including memory, attention, language, executive functions (reasoning, logical thinking), and visual and spatial skills. Specifically, we included nine cognitive games related to executive functions, e.g., Turn around, Points of View, Basketball in New York, Sleight of Hands, Towers of Hanoi, and information processing speed, e.g., Sleights of hands, Entangled Figures, Towers of Hanoi, Under Pressure, Shapes and Colors, Private Eye Turn around, Points of View. A detailed description of each game can be found in Appendix Table 1. For the purpose of the current study, we have defined the same level of difficulty for each game to all participants. Each patient was asked to complete all nine cognitive games in the same order using the computer keyboard. For each cognitive game, average accuracy and response time were recorded.

Game training adherence assessment

The adherence rate in the game training group was assessed weekly using the HN platform to ensure patients keep training twice weekly for 30 minutes’ sessions. Subjects that missed more than 20% of the training sessions over time were excluded from the analysis

Statistical Analysis

All measured variables and derived parameters were tabulated by descriptive statistics. Paired T-test (paired observations) was applied for testing the statistical significance of the change in the executive function and in information processing speed from baseline at month 3 and month 6 within each study group.

The two-sample T-test was applied to compare the relative change in executive function and information processing speed from baseline between Training and Non-Training groups at month 3 and month 6.

A linear model for repeated measures was applied for analyzing the difference between Training and Non-Training groups in executive function change and in information processing speed change from baseline at any time, including the fixed effect time and adjusted for baseline.

Chi-Square Test was applied to compare the frequency of improvement in executive function and in information processing speed between Training and Non-Training groups at month 3 and month 6.

The data were analyzed using the SAS ® version 9.4 (SAS Institute, Cary North Carolina).

Demographics

164 subjects were evaluated for eligibility, 100 of which fulfilled all inclusion criteria and were included in the study. 51 subjects were randomized into the Training group, and 49 into the Non-Training group. Ninety-three subjects completed the 3-month follow up, and 87 subjects completed the 6-months follow up.

Clinical and cognitive variables of the study participants by group are presented in Table 1.

Table 1

Clinical and cognitive variables of the study participants by group.
Mean ± SD Median	ALL N = 100	TRAINING N = 51	NON-TRAINING N = 49	p
AGE, years	43.8 ± 7.29 45.7	41.8 ± 7.9 42.6	46.0 ± 6.0 47.1	< 0.001
GENDER, F:M	74:26	36:15	38:11
EDUCATION, years	14.2 ± 2.31 14	14.5 ± 2.31 14	14.0 ± 2.30 14	0.136
DISEASE DURATION, years	14.2 ± 7.93 13.6	12.7 ± 7.92 11.4	15.7 ± 7.71 16.0	< 0.001
EDSS	2.6 ± 1.70 2.0	2.7 ± 1.69 2.0	2.65 ± 7.93 2.0	0.346
INTERFERON-BETA-1A Tx DURATION, years	6.7 ± 4.48 5.5	5.3 ± 3.58 4.2	8.2 ± 4.87 7.6	< 0.001
EXECUTIVE FUNCTION	91.8 ± 12.74 93.5	91.4 ± 12.59 93.0	92.2 ± 13.02 95.0	0.367
INFORMATION PROCESSING SPEED	84.7 ± 14.07 85.0	86.0 ± 13.0 88.0	83.3 ± 15.14 82.0	0.174

Randomization was performed only for cognitive performance and EDSS which were the major important variables to ensure similar cognitive performance and disease characteristics before cognitive game practice.

At baseline, performance in executive function and information processing speed did not differ between the Training and Non-Training groups, scores being 91.4 vs. 92.2 and 86 vs. 83.3, respectively.

Effect of targeted cognitive game training on cognitive performance over time

The results of targeted cognitive game training on executive function and information processing speed over time are shown in Figs. 1A and 1B, respectively.

Executive Function

At 3 months from baseline, mean (± SD) score in executive function was 95.9 ± 14.0, and 91.8 ± 13.7 for the Training and Non-Training groups respectively (p = 0.157 for unpaired T-test). At 6 months, executive function scores were 97.6 ± 16.0, and 88.3 ± 13.5 for the Training and Non-Training groups respectively (p = 0.005).

The Training group demonstrated a statistically significant improvement in executive function after 3 and after 6 months (paired T-test, p = 0.0035 and p = 0.0007, respectively). The Non-Training group showed mild but non-significant deterioration in executive function at 3 months (p = 0.1634), and further decline that became statistically significant at 6 months (p = 0.0036).

Information Processing Speed

At 3 months from baseline, mean (± SD) score in information processing speed was 91.3 ± 14.0, and 82.7 ± 16.2 for the Training and Non-Training groups respectively (p = 0.007 for unpaired T-test). At 6 months, information processing speed scores were 92.5 ± 16.6, and 80.2 ± 15.8 for the Training and Non-Training groups respectively (p < 0.001).

The game training group demonstrated a statistically significant improvement after 3 and after 6 months (paired T-test, p = 0.0013 and p > 0.001, respectively). The non-training group showed mild deterioration in information processing speed performance that was not significant at 3 months (p = 0.4978) and further mild decline at 6 months (p = 0.0687).

Effect of targeted cognitive game training on the frequency of patients with stable or improved cognitive performance over time

The frequency of patients that either improved/remained stable, or worsened in cognitive performance over time in relation to targeted cognitive training are shown in Fig. 2A-D.

For both cognitive domains, no statistically significant differences were observed regarding the frequency of improvement in patients at 3 months from baseline (p = 0.28 and p = 0.45 for executive function and information processing speed, respectively). However, at 6 months, the percent of patients in the Training group that improved or remained stable in both cognitive domains was significantly higher compared to the Non-Training group (p < 0.001 and p = 0.01 for executive function and information processing speed, respectively).

Adherence To The Cognitive Game Training

The majority of MS patients in the Training group had a good compliance rate; 13.7% of the patients missed 5 sessions during the 3 months training, and 19.6% missed 5 sessions during the 3 to 6 months training sessions.

Targeted cognitive training holds promise in promoting cognitive performance in patients suffering from MS, and specifically in young MS patients with mild cognitive decline. These subjects have the ability to use computerized gaming and can easily practice; moreover, the variety and diversity of the various games, along with the options to gradually increase the difficulty of the games to match each participant’s abilities, constitute major advantages for the rehabilitation process that enable personalized targeted cognitive training. Developing targeted tools such as cognitive game training platforms to detain cognitive decline is of significant importance for these patients, as they may develop cognitive decline at an early disease stage. One of the pressing questions is how to assess the effectiveness of various cognitive game training systems in real-world settings and the possible improvement in cognitive performance while considering age and educational level of users, system and environmental constraints, type of feedback, and adherence to training. In the current study, we employed an interactive game training exercise system that was targeted to patients with MS suffering from mild cognitive impairment in either executive function or information processing speed and assessed their cognitive performance after 3 and 6 months of practice, in comparison to disability- and cognitive-performance matched group of MS patients that did not practice the targeted cognitive game training platform. In our previous study, we demonstrated that cognitive decline first occurs at five years from onset, suggesting the existence of a therapeutic window during which patients may benefit from interventions to maintain cognitive health (2). In the current study, all patients had a longer disease duration (median 14.2 years), beyond the cognitive protective 5-year window. It is conceivable to suggest that treatment with interferon-beta-1a for a median of 5.5 years had a protective effect on cognition as all patients had only mild cognitive impairment.

Our findings demonstrated that MS patients that practiced cognitive training improved their cognitive performance within a short period of practicing. Executive function performance significantly increased at as early as 3 months, while in non-training patients, executive function performance significantly decreased at 6 months. Information processing speed significantly increased over 3 and 6 months, while in non-training patients, information processing speed performance mildly decreased at 6 months. These findings imply that game training can contribute to better performance in daily activities that require these cognitive capabilities.

The compliance rate for training was relatively high, suggesting that the gamification approach is effective in improving patients’ motivation and enjoyment while practicing. The ability to remind patients to participate in the training and assess their compliance was unique to the current study. This was achieved through the HN computerized platform and the ability to evaluate the training sessions by remote control.

Previous studies in older populations with impaired cognition showed that cognitive training can produce moderate to large beneficial effects on memory related-outcomes (26), and enhance cognitive control (21), due to brain plasticity-related mechanisms (27, 28). The only study that assessed the effect of a 3-month cognitive training program in MS patients with mild-to-moderate cognitive impairment, included 30 subjects that received a computer-assisted neuropsychological training program and 32 subjects that were randomized to no intervention (29). The rehabilitation program focused on attention, processing speed, memory, and executive function through computerized and paper and pencil tasks. Similar to our findings, the computer-assisted neuropsychological training group showed significant improvements in memory and phonetic fluency while the non-training group did not show similar changes. In their study, no data were provided concerning immunomodulatory treatment and adherence to the cognitive training.

The limitation of our study is that we did not evaluate the longevity of the cognitive training effect after cessation of training. We suspect that without practice the effect will not be sustained, similarly to any physical exercise or training activities whereby practice is mandatory.

To the best of our knowledge, this is the first study to directly compare the correlations between cognitive training games and cognitive assessment in a large cohort of patients for 6 months. The finding that targeted cognitive game training significantly improved performance of both information processing speed and executive function is encouraging, suggesting that game tasks involving both planning and decision-making elements can contribute to cognitive performance in day-to-day activities. Our findings may indicate the importance of targeted cognitive rehabilitation for young patients with brain damage leading to mild cognitive impairment. We recommend to MS patients to be engaged in cognitive gaming practice as part of a holistic healthcare approach that integrates many cognitive aspects in daily life, e.g. chess playing, solving puzzles or sudoku, and computerized gaming, to prevent cognitive deterioration and enhance neural plasticity.

In conclusion, in this prospective study we showed that targeted cognitive game training significantly improved performance of both information processing speed and executive function in MS patients within 6 months of training. These findings suggests a beneficial effect of game training in the rehabilitative process of patients suffering from MS.

MS

Multiple Sclerosis; HN:HappyNeuron; EDSS:Expanded Disability Status Score

Ethical approval and consent to participate

Ethical approval to conduct the study was granted by the Sheba Medical Center Ethics Committee (Institutional Review Board number SMC-333016), and each participant signed written informed consent.

Consent for publication

Not applicable.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests

SM - has received honoraria or consulting fees from Biogen, Bristol Myers Squibb, Merck KGaA, Roche, Novartis and Sanofi-Genzyme and research support from Biogen, Merck KGaA, Roche, and Sanofi-Genzyme;

RA reports no competing interests;

MD reports no competing interests;

DM reports no competing interests;

KG reports no competing interests;

SDA reports no competing interests;

FTB reports no competing interests;

RA reports no competing interests;

GH reports no competing interests;

AA - has received honoraria or consulting fees from Biogen, Bristol Myers Squibb, Merck KGaA, Roche, Novartis and Sanofi-Genzyme; and research support from Biogen, Merck KGaA, Roche, and Sanofi-Genzyme.

Funding

This Investigator-Initiated Research was supported by Merck KGaA, Darmstadt, Germany (10.13039/100009945) Research Grant (MS200136).

Authors’ contributions

SM: Drafting/revision of the manuscript for content, including medical writing for content; Major role in the acquisition of data.

RA: Drafting/revision of the manuscript for content, including medical writing for content; Major role in the acquisition of data; Study concept or design.

MD: Drafting/revision of the manuscript for content, including medical writing for content; Major role in the acquisition of data.

DM: Drafting/revision of the manuscript for content, including medical writing for content; Major role in the acquisition of data.

KG: Drafting/revision of the manuscript for content, including medical writing for content; Major role in the acquisition of data.

SDA: Drafting/revision of the manuscript for content, including medical writing for content; Analysis or interpretation of data.

FTB: Drafting/revision of the manuscript for content, including medical writing for content; Study concept or design.

RA: Drafting/revision of the manuscript for content, including medical writing for content; Analysis or interpretation of data.

GH: Drafting/revision of the manuscript for content, including medical writing for content; Analysis or interpretation of data.

AA: Drafting/revision of the manuscript for content, including medical writing for content; Study concept or design; Major role in the acquisition of data; Analysis or interpretation of data.

Acknowledgements:

We thank Tali Paz, MsC, Ms. Hen Eisikovitz, Ms. Maria Didkin, and Mrs. Sue Mayust for their outstanding technical help in collecting the data.

Harel Y, Kalron A, Menascu S, Magalashvili D, Dolev M, Doniger G, Simon E, Achiron A. Cognitive function in multiple sclerosis: A long-term look on the bright side. PLoS One. 2019;14(8):e0221784.
Achiron A, Chapman J, Magalashvili D, Dolev M, Lavie M, Bercovich E, Polliack M, Doniger GM, Stern Y, Khilkevich O, Menascu S, Hararai G, Gurevich M, Barak Y. Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One. 2013;8(8):e71058.
Achiron A, Barak Y. Cognitive changes in early MS: a call for a common framework. J Neurol Sci. 2006;245:47–51.
Ballesteros S, Prieto A, Mayas J, Toril P, Pita C, Ponce de León L, Reales JM, Waterworth J. Brain training with non-action video games enhances aspects of cognition in older adults: a randomized controlled trial. Front Aging Neurosci. 2014;6:277.
Nikolaidis A, Voss MW, Lee H, Vo LT, Kramer AF. Parietal plasticity after training with a complex video game is associated with individual differences in improvements in an untrained working memory task. Front Hum Neurosci. 2014;8:169.
Vleet TV, DeGutis J, Dabit S, Chiu C. Randomized control trial of computer-based rehabilitation of spatial neglect syndrome: the RESPONSE trial protocol. BMC Neurol. 2014;14:25.
Cameirão MS, Badia SB, Oller ED, Verschure PF. Neurorehabilitation using the virtual reality based Rehabilitation Gaming System: methodology, design, psychometrics, usability and validation. J Neuroeng Rehabil. 2010;7:48.
Lampit A, Heine J, Finke C, Barnett MH, Valenzuela M, Wolf A, Leung IHK, Hill NTM. Computerized Cognitive Training in Multiple Sclerosis: A Systematic Review and Meta-analysis. Neurorehabil Neural Repair. 2019 Sep;33(9):695–706.
Achiron A, Doniger GM, Harel Y, Appleboim-Gavish N, Lavie M, Simon ES. Prolonged response times characterize cognitive performance in multiple sclerosis. Eur J Neurol. 2007;14:1102–8.
Achiron A, Polliack M, Rao SM, Barak Y, Lavie M, Appelboim N, Harel Y. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry. 2005;76:744–9.
Cramer SC, Sur M, Dobkin BH, O'Brien C, Sanger TD, Trojanowski JQ, Rumsey JM, Hicks R, Cameron J, Chen D, Chen WG, Cohen LG, deCharms C, Duffy CJ, Eden GF, Fetz EE, Filart R, Freund M, Grant SJ, Haber S, Kalivas PW, Kolb B, Kramer AF, Lynch M, Mayberg HS, McQuillen PS, Nitkin R, Pascual-Leone A, Reuter-Lorenz P, Schiff N, Sharma A, Shekim L, Stryker M, Sullivan EV, Vinogradov S. Harnessing neuroplasticity for clinical applications. Brain. 2011;134(Pt 6):1591–609.
Cohen LG, Celnik P, Pascual-Leone A, Corwell B, Falz L, Dambrosia J, Honda M, Sadato N, Gerloff C, Catalá MD, Hallett M. (1997) Functional relevance of cross-modal plasticity in blind humans. Nature. 1997;389(6647):180-3.
Heinzel S, Lorenz RC, Pelz P, Heinz A, Walter H, Kathmann N, Rapp MA, Stelzel C. Neural correlates of training and transfer effects in working memory in older adults. Neuroimage. 2016;134:236–49.
Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006;7(9):697–709.
van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci. 2000;1(3):191–8.
Biernaskie J, Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J Neurosci. 2001;21(14):5272–80.
Malá H, Rasmussen CP. The effect of combined therapies on recovery after acquired brain injury: Systematic review of preclinical studies combining enriched environment, exercise, or task-specific training with other therapies. Restor Neurol Neurosci. 2017;35(1):25–64.
Motter JN, Pimontel MA, Rindskopf D, Devanand DP, Doraiswamy PM, Sneed JR. Computerized cognitive training and functional recovery in major depressive disorder: a meta-analysis. J Affect Disord 2016 Jan 1;189:184–191.
Coyle H, Traynor V, Solowij N. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature. Am J Geriatr Psychiatry. 2015 Apr;23(4):335–59.
Al-Thaqib A, Al-Sultan F, Al-Zahrani A, Al-Kahtani F, Al-Regaiey K, Iqbal M, Bashir S. Brain training games enhance cognitive function in healthy subjects. Med Sci Monit Basic Res. 2018;24:63–9.
Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, Kong E, Larraburo Y, Rolle C, Johnston E, Gazzaley A. Video game training enhances cognitive control in older adults. Nature. 2013;501(7465):97–101.
Li K, Robertson J, Ramos J, Gella S. Computer-based cognitive retraining for adults with chronic acquired brain injury: a pilot study. Occup Ther Health Care. 2013;27(4):333–44.
Achiron A, Aloni R, Croisile B, Gurevich M, Doniger GM, Tarpin-Bernard F. Design and evaluation. (2019) IEEE 7th International Conference on Serious Games and Applications for Health (SeGAH) Conference Paper. https://ieeexplore.ieee.org/search/searchresult.jsp?newsearch=true&queryText=Achiron.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov 1;33(11):1444-.
Gates NJ, Sachdev PS, Fiatarone Singh MA, Valenzuela M. Cognitive and memory training in adults at risk of dementia: a systematic review. BMC Geriatr. 2011;11:55.
Klingberg T. Training and plasticity of working memory. Trends Cogn Sci. 2010;14(7):317–24.
Smith GE1, Housen P, Yaffe K, Ruff R, Kennison RF, Mahncke HW, Zelinski EM. A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study. J Am Geriatr Soc. 2009;57(4):594–603.
Pérez-Martín MY, González-Platas M, Eguía-Del Río P, Croissier-Elías C, Jiménez Sosa A. Efficacy of a short cognitive training program in patients with multiple sclerosis. Neuropsychiatr Dis Treat. 2017;13:245–52.

appendix.docx

Targeted Cognitive Game Training Enhances Cognitive Performance in Multiple Sclerosis Patients Treated With Interferon Beta 1-a

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Methods

Results

Discussion

Conclusions

List Of Abbreviations

Declarations

References

Supplementary Files

Status:

Journal Publication

Version 1